HematologyAt Hackensack Meridian Children’s Health, we provide best-in-class treatment for children with blood disorders. Our team includes dedicated pediatric hematologists, advanced practice nurses, social workers and psychologists, and pain and palliative care clinicians. We diagnose and treat conditions, including:
- Anemia (lack of red blood cells, causing a faint feeling) – hemolytic, iron deficiency, megaloblastic
- Bleeding and clotting disorders
- Bone marrow failure syndromes (Diamond Black-fan anemia, Fanconi anemia, Shwachman-Diamond syndrome
- Destructive cytopenias (ITP immune thrombocytopenia purpura)
- Myelodysplastic syndrome
- Neutropenias (low blood count of neutrophils that fight off bacteria and infections)
- Paroxysmal nocturnal hemoglobinuria
- Sickle cell disease
- Thalassemia (alpha and beta)
- Thrombocytopenia(low blood platelets)
- Von Willebrand disease
Our Hackensack location is a referral center for the State Newborn Screening for hemoglobinopathy. We follow patients with sickle cell disease and thalassemia through adulthood.
Our services and capabilities include:
- Stem cell transplantation*
- Infusion therapies
- Pediatric intensive care unit (PICU)
- Genetic testing and counseling
- On-site laboratory
- State-of-the-art diagnostic imaging services
- Hematology registries and clinical trials*
- Home care for patients with hemophilia and Von Willebrand disease*
- Stem cell transplant for sickle cell anemia
*Service only available at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center
We provide transplantation for patients with sickle cell anemia who have human leukocyte antigen (HLA) matched sibling donors. Our participation in a national study extended the transplant option to patients without matched siblings, but with matched unrelated donors.
A current clinical trial focuses on reduced intensity conditioning regimens for non-malignant diseases, such as sickle cell anemia and thalassemia.
Pediatric Thrombosis Program
The Thrombosis Program’s mission is to provide a standardized approach for the prevention, evaluation, and treatment of blood clots in children’led by experts in hematological care. Our early detection and treatments, in addition to our participation in national clinical trials, seek to provide children at-risk of, or currently diagnosed with, venous and arterial thrombosis the latest in early detection and evidence-based treatments. This will include establishing new anticoagulation and diagnostic protocols for children who are higher risk for developing the condition, such as pediatric patients with chronic conditions and those receiving cancer treatments.
- What pediatric diagnoses are particularly vulnerable to blood clots?
- Hemoglobinopathies (including thalassemia’s and sickle cell disease)
- Hemostasis (including von Willebrand disease, hemophilia, and coagulopathies)
- Platelet disorders
- When is a thrombosis specialist most critical to manage care?
- Post-operative Patients
- ICU Patients
- COVID-19 Patients
- Patients undergoing IV Chemotherapy
We provide services to reduce difficulties for children, teens and young adults with sickle cell disease and related hemoglobin disorders:
- Disease education
- Personal and school counseling
- Financial counseling
- Genetic counseling
- Community education programs
- Public awareness campaigns
- Patient and family advocacy
Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center
30 Prospect Ave, Hackensack, NJ 07601
K. Hovnanian Children's Hospital at Jersey Shore University Medical Center
19 Davis Avenue, 5th Floor, Neptune, NJ 07753
JFK University Medical Center
102 James Street, Suite 303, Edison, NJ 08820
Our team includes dedicated pediatric hematologists, advanced practice nurses, social workers and psychologists, and pain and palliative care clinicians.